Citation Impact
Citing Papers
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
2001 StandoutScienceNobel
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
2001 StandoutScienceNobel
A hexahistidine-Zn 2+ -dye label reveals STIM1 surface exposure
2007 StandoutNobel
Peptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXR
2001
Oxygen-regulated and Transactivating Domains in Endothelial PAS Protein 1: Comparison with Hypoxia-inducible Factor-1α
1999 StandoutNobel
Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: Necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins
1990
Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries
1991
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Rac1 Activity Is Required for the Activation of Hypoxia-inducible Factor 1
2001 StandoutNobel
Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
1996 Standout
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
2006
The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects
2005
Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells
1996
Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome
2007
Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit
1997 StandoutNobel
Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α
1997 StandoutNobel
Hypoxic Regulation of Lactate Dehydrogenase A
1995 StandoutNobel
Oxygen sensing and signaling: impact on the regulation of physiologically important genes
1999
The metabolic syndrome
2010 Standout
Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes
2001
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
1999 StandoutNatureNobel
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction
2002
Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery
1996
Coronary bypass graft fate: Long-term angiographic study
1991
Relationship between Abdominal Fat Compartments and Glucose and Lipid Metabolism in Early Postmenopausal Women1
2001
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
High prevalence of metabolic syndrome among young women with premature coronary artery disease
2005
Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-up
1992
Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial
2006
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Nickel carcinogenesis
2003 Standout
Purification and Characterization of Hypoxia-inducible Factor 1
1995 StandoutNobel
Short-Term Effects of Transdermal Estrogen Replacement Therapy on Coronary Vascular Reactivity in Postmenopausal Women With Angina Pectoris and Normal Results on Coronary Angiograms
1998
Nickel essentiality, toxicity, and carcinogenicity
2002
Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
1990
Myocardial Reperfusion Injury
2007 Standout
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Metabolic syndrome and mortality in stable coronary heart disease: Relation to gender
2007
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Perspectives on Oxygen Sensing
1999 StandoutNobel
Regulation of the Erythropoietin Gene
1989
The Role of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) in Hypoxic Induction of Gene Expression
1996 StandoutNobel
Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences
1995 StandoutNobel
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Prevention of 7, 12-dimethylbenz(α)anthracene-induced adrenal necrosis by cyproterone acetate
1973
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
2004 Standout
Morphologie Changes in Long-term Saphenous Vein Bypass Grafts
1985
Genetic Models of Human Vascular Disease
1995 StandoutNobel
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
1993 StandoutNobel
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
1995 StandoutNobel
Smoking and Cardiac Events After Venous Coronary Bypass Surgery
1996
Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.
1981
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
2006
Functional Arteries Grown in Vitro
1999 StandoutScience
Late results of coronary artery grafting: Is there a flag on the field?
1984
The Chemical Defenses of Plants to Pathogens and Herbivores
1976
Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism.
1993 StandoutNobel
Regulation of the Erythropoietin Gene: Evidence That the Oxygen Sensor Is a Heme Protein
1988 Science
Prostacyclin is a circulating hormone
1978 StandoutNatureNobel
Resource Availability and Plant Antiherbivore Defense
1985 StandoutScience
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice.
1991 StandoutNobel
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.
1994 StandoutNobel
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Vein graft disease: The clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries
1992
Predictors and Sequelae of Distal Embolization During Saphenous Vein Graft Intervention From the CAVEAT-II Trial
1995
Late results of coronary artery grafting: Is there a flag on the field?: Reply
1984
Renin promoter SV40 T-antigen transgenic mouse. A model of primary renal vascular hyperplasia.
1991
The Metabolic Syndrome
2008 Standout
Harmonizing the Metabolic Syndrome
2009 Standout
Coronary bypass graft fate
1986
Arene Oxides: A New Aspect of Drug Metabolism
1974 StandoutScience
Perioperative myocardial infarction complicating coronary bypass
1981
Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.
1991 StandoutNobel
Graft disease in patients with coronary bypass grafting
1986
Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene.
1991 StandoutNobel
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
2000 StandoutScience
Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.
1993 StandoutNobel
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
1977 StandoutNobel
Reoperation in patients with patent atherosclerotic coronary vein grafts
1984
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
Works of B Solymoss being referenced
Studies of the mechanism of polycythemia induced in rats by Ni3S2.
1978
Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women
1995
Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity
2004
Effects of cold and warm blood cardioplegia assessed by myocardial pH and release of metabolic markers
1994
Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease
2003
'True' fasting serum insulin level, insulin resistance syndrome and coronary artery disease
1997
Long-term rates of cardiovascular events in patients with the metabolic syndrome according to severity of coronary-angiographic alterations
2008
Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio
1993
Protection by spironolactone and oxandrolone against chronic digitoxin or indomethacin intoxication
1971
Polycythemia Induced in Rats by Intrarenal Injection of Nickel Sulfide Ni3S2
1975
Increased Canalicular Bile Production Induced by Pregnenolone-16 -Carbonitrile, Spironolactone and Cortisol in Rats
1974
Late thrombosis of saphenous vein coronary bypass grafts related to risk factors.
1988
Atherosclerotic changes in coronary vein grafts six years after operation
1979
Atherosclerotic changes in coronary vein grafts six years after operation. Angiographic aspect in 110 patients.
1979
Metaplastic and mitotic activity of the ischemic (endocrine) kidney in experimental renal hypertension.
1979
Suppression of 7, 12-dimethylbenz[α]anthracene-produced adrenal necrosis by steroids capable of inducing aryl hydrocarbon hydroxylase
1971
Pathologic changes in coronary artery saphenous vein grafts and related etiologic factors.
1991
Growth of neonatal hamster skeletal muscle in culture
1981
The Alterations of Venous Endothelium in Experimental Thrombosis Produced by Catecholamines and Metals
1967
MB Creatine Kinase and the Evaluation of Myocardial Injury Following Aortocoronary Bypass Operation
1980
The Topical Effects of Nickel Subsulfide on Renal Parenchyma
1978
Prevention of Hereditary Cardiomyopathy in the Hamster by Verapamil and Other Agents
1975